First Time Loading...

Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 95.2 USD -0.19% Market Closed
Updated: May 8, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Income Statement

1.3B
+2%
Revenue
Growth Rates:
1 Year
+12%
3 Years
+44%
5 Years
+33%
7 Years
+41%
10 Years
+34%
199.3m
+8%
Operating Income
Growth Rates:
1 Year
+37%
3 Years
+89%
5 Years
+87%
7 Years
+396%
10 Years
+54%
126.5m
-1%
Net Income
Growth Rates:
1 Year
+32%
3 Years
+17%
5 Years
+174%
7 Years
+681%
10 Years
+237%

Earnings Waterfall
Haemonetics Corp

Revenue
1.3B USD
Cost of Revenue
-590.8m USD
Gross Profit
679.3m USD
Operating Expenses
-480m USD
Operating Income
199.3m USD
Other Expenses
-72.8m USD
Net Income
126.5m USD

Income Statement
Haemonetics Corp

Rotate your device to view
Income Statement
Currency: USD
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Apr-2016 Jul-2016 Oct-2016 Dec-2016 Apr-2017 Jul-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Dec-2022 Apr-2023 Jul-2023 Sep-2023 Dec-2023
Revenue
Revenue
947
N/A
939
-1%
944
+1%
935
-1%
925
-1%
910
-2%
899
-1%
891
-1%
893
+0%
909
+2%
905
0%
906
+0%
900
-1%
886
-2%
887
+0%
892
+1%
899
+1%
904
+1%
922
+2%
939
+2%
952
+1%
968
+2%
977
+1%
988
+1%
999
+1%
989
-1%
946
-4%
903
-5%
884
-2%
871
-2%
903
+4%
934
+3%
953
+2%
993
+4%
1 026
+3%
1 084
+6%
1 129
+4%
1 169
+3%
1 219
+4%
1 239
+2%
1 270
+2%
Gross Profit
Cost of Revenue
(471)
(470)
(480)
(484)
(484)
(476)
(469)
(464)
(468)
(503)
(511)
(513)
(515)
(508)
(508)
(513)
(509)
(492)
(498)
(507)
(520)
(529)
(527)
(522)
(517)
(501)
(486)
(465)
(454)
(463)
(486)
(499)
(500)
(468)
(487)
(509)
(534)
(546)
(578)
(586)
(591)
Gross Profit
476
N/A
468
-2%
463
-1%
451
-3%
442
-2%
434
-2%
431
-1%
428
-1%
425
-1%
406
-5%
395
-3%
393
0%
386
-2%
379
-2%
379
+0%
380
+0%
390
+3%
412
+6%
425
+3%
432
+2%
432
0%
439
+2%
450
+3%
465
+3%
482
+4%
488
+1%
459
-6%
438
-5%
430
-2%
408
-5%
418
+3%
435
+4%
454
+4%
526
+16%
540
+3%
575
+7%
595
+4%
623
+5%
640
+3%
653
+2%
679
+4%
Operating Income
Operating Expenses
(346)
(420)
(360)
(362)
(356)
(331)
(385)
(375)
(352)
(362)
(450)
(443)
(345)
(339)
(314)
(309)
(309)
(312)
(314)
(323)
(325)
(320)
(323)
(312)
(308)
(314)
(314)
(320)
(324)
(334)
(357)
(375)
(394)
(425)
(420)
(434)
(449)
(455)
(458)
(469)
(480)
Selling, General & Administrative
(301)
(366)
(304)
(299)
(288)
(259)
(278)
(287)
(300)
(317)
(317)
(314)
(306)
(302)
(280)
(276)
(271)
(273)
(274)
(281)
(287)
(285)
(289)
(279)
(277)
(284)
(283)
(290)
(294)
(269)
(274)
(277)
(281)
(332)
(331)
(349)
(365)
(373)
(374)
(385)
(396)
Research & Development
(46)
(54)
(48)
(48)
(46)
(43)
(42)
(44)
(45)
(45)
(45)
(42)
(39)
(38)
(34)
(34)
(37)
(39)
(40)
(42)
(38)
(36)
(34)
(33)
(31)
(30)
(31)
(30)
(31)
(32)
(38)
(42)
(44)
(46)
(45)
(45)
(48)
(49)
(52)
(54)
(54)
Depreciation & Amortization
0
0
(8)
(15)
(23)
(30)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(33)
(45)
(57)
(69)
(47)
(44)
(40)
(36)
(33)
(32)
(31)
(30)
Other Operating Expenses
0
0
0
0
0
0
(65)
(45)
(7)
0
(88)
(88)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
130
N/A
48
-63%
103
+115%
89
-14%
85
-4%
103
+21%
46
-56%
53
+15%
73
+39%
44
-40%
(56)
N/A
(50)
+10%
40
N/A
39
-2%
65
+66%
70
+7%
81
+16%
100
+23%
111
+11%
109
-1%
107
-2%
118
+11%
127
+7%
154
+21%
175
+14%
174
0%
145
-17%
117
-19%
105
-10%
74
-30%
61
-17%
60
-2%
59
-1%
101
+70%
120
+19%
141
+17%
146
+4%
168
+15%
182
+8%
184
+1%
199
+8%
Pre-Tax Income
Interest Income Expense
(11)
(10)
(10)
(10)
(9)
(9)
(9)
(9)
(9)
(10)
(10)
(9)
(9)
(8)
(7)
(7)
(5)
(5)
(5)
(7)
(9)
(10)
(12)
(14)
(14)
(16)
(16)
(15)
(15)
(17)
(18)
(18)
(20)
(17)
(18)
(19)
(16)
(15)
(12)
(8)
(9)
Non-Reccuring Items
(77)
(2)
(52)
(49)
(45)
(63)
0
0
(100)
(88)
0
0
(8)
(59)
(52)
(57)
(89)
(36)
(66)
(63)
(33)
(35)
(62)
(65)
(74)
(71)
(17)
20
32
16
18
(15)
(19)
(20)
(10)
(8)
(6)
(12)
(3)
(16)
(29)
Pre-Tax Income
41
N/A
36
-12%
42
+14%
30
-27%
31
+3%
31
-1%
37
+19%
44
+18%
(35)
N/A
(53)
-51%
(65)
-22%
(59)
+10%
23
N/A
(28)
N/A
6
N/A
6
+2%
(13)
N/A
60
N/A
40
-33%
40
+0%
65
+64%
74
+13%
53
-29%
75
+42%
87
+16%
87
+0%
113
+29%
123
+9%
122
0%
73
-40%
62
-15%
27
-57%
21
-22%
64
+204%
92
+45%
113
+23%
124
+10%
141
+14%
168
+18%
159
-5%
161
+1%
Net Income
Tax Provision
(4)
(1)
(2)
0
(1)
(14)
(17)
(18)
(14)
(2)
(1)
0
(7)
1
(2)
(1)
23
14
11
9
(19)
(19)
(3)
(7)
(7)
(11)
(17)
(17)
(14)
7
3
4
2
(20)
(25)
(27)
(28)
(26)
(31)
(31)
(34)
Income from Continuing Operations
38
35
39
30
30
17
20
26
(50)
(56)
(66)
(59)
16
(26)
4
5
11
73
51
49
46
55
49
68
80
77
96
106
108
80
65
31
23
43
68
86
96
115
137
128
127
Net Income (Common)
38
N/A
35
-6%
39
+12%
30
-23%
30
-1%
17
-44%
20
+20%
26
+27%
(50)
N/A
(56)
-12%
(66)
-18%
(59)
+11%
16
N/A
(26)
N/A
4
N/A
5
+7%
(17)
N/A
46
N/A
23
-50%
21
-6%
46
+116%
55
+19%
49
-10%
68
+38%
80
+17%
77
-4%
96
+25%
106
+11%
108
+2%
80
-26%
65
-19%
31
-51%
23
-28%
43
+92%
68
+56%
86
+27%
96
+11%
115
+21%
137
+18%
128
-6%
127
-1%
EPS (Diluted)
0.72
N/A
0.67
-7%
0.75
+12%
0.57
-24%
0.57
N/A
0.32
-44%
0.38
+19%
0.49
+29%
-0.99
N/A
-1.09
-10%
-1.29
-18%
-1.13
+12%
0.31
N/A
-0.51
N/A
0.08
N/A
0.08
N/A
-0.32
N/A
0.85
N/A
0.43
-49%
0.4
-7%
0.86
+115%
1.04
+21%
0.96
-8%
1.3
+35%
1.53
+18%
1.48
-3%
1.85
+25%
2.07
+12%
2.11
+2%
1.55
-27%
1.25
-19%
0.6
-52%
0.43
-28%
0.84
+95%
1.31
+56%
1.66
+27%
1.85
+11%
2.24
+21%
2.66
+19%
2.5
-6%
2.47
-1%

See Also

Summary
HAE intrinsic value, competitors valuation, and company profile.
DCF Valuation
HAE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HAE stock valuation using valuation multiples.
Wall Street Estimates
HAE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HAE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.